Vivaldi Biosciences News
Most Popular Vivaldi Biosciences Story
Nasal delivery: the future of the flu vax
WASHINGTON, DC - A fear of needles has kept many from getting optional vaccines, including the one for pandemic flu. And panel members at this year's Influenza Congress USA believe the future of the Read more...
Latest Headlines
- November 11, 2010
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
More Research Reports >>
